GILD – gilead sciences, inc. (US:NASDAQ)

News

Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025 [Yahoo! Finance]
Gilead Sciences (NasdaqGS:GILD) Advances HIV Treatment With Promising Lenacapavir And Biktarvy Data [Yahoo! Finance]
GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive [Yahoo! Finance]
Vantis Health completes €10m funding round to advance primary care [Yahoo! Finance]
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com